| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000019621 |
| Receipt No. | R000022517 |
| Official scientific title of the study | Development of a novel hypoxic training method using carbon dioxide. |
| Date of disclosure of the study information | 2015/11/05 |
| Last modified on | 2018/11/16 (Ver. 8) |
| Basic information | ||
| Official scientific title of the study | Development of a novel hypoxic training method using carbon dioxide. | |
| Title of the study (Brief title) | Development of a novel hypoxic training method using carbon dioxide. | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adults subjects | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | In competitive sports, high-altitude training enhances the effects of training but can be associated with a risk of overtraining, since recovery from fatigue through sleep is slower at high altitude than at sea level. High-altitude sleep is characterized by reduced sleep quality resulting from an increase in arousal during sleep and a decrease in the duration of slow-wave sleep due to central sleep apnea.
The objectives of this study are to establish a novel hypoxic training method (hypoxic carbon dioxide loading) that involves artificially controlling end-tidal carbon dioxide partial pressure during sleep in a hypoxic environment to values experienced during normal sleep at sea level in order to reduce central apnea and to obtain physiological basic data that provide scientific evidence for the training method. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Apnea |
| Key secondary outcomes | Sleep structure, End-tidal carbon dioxide partial pressure: |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | After normal sleep conditions, hypoxic sleep conditions will be performed and subsequently hypoxic carbon dioxide load sleep conditions will be performed. Exposure time under sleep conditions will be 7 hours. Three conditions will be three days successively.
Oxygen concentration of inspiration will be set at 15.4%, which corresponds to the concentration at 2500 m above sea level in hypoxic sleep conditions. During sleep hypoxic carbon dioxide load sleep conditions, oxygen concentration of inspiration will be set at 15.4% and the carbon dioxide concentration in the sleeping room will be adjusted 1500 ppm. |
|
| Interventions/Control_2 | After normal sleep conditions, hypoxic carbon dioxide load sleep conditions will be performed and subsequently hypoxic sleep conditions will be performed. Exposure time under sleep conditions will be 7 hours. Three conditions will be three days successively.
Oxygen concentration of inspiration will be set at 15.4%, which corresponds to the concentration at 2500 m above sea level in hypoxic sleep conditions. During sleep hypoxic carbon dioxide load sleep conditions, oxygen concentration of inspiration will be set at 15.4% and the carbon dioxide concentration in the sleeping room will be adjusted 1500 ppm. |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Inclusion criteria are as follows:
Be in good health. Be aged over 20 years at the time of giving consent to study participation. Be able to fully understand this study plan and give their own consent, and have signed and dated the informed consent form prior to starting the study. Have normal nocturnal sleep patterns. Be able to sleep at the university laboratory at night. Be able to comply with the specified sleep/arousal rhythm. |
|||
| Key exclusion criteria | Outpatients judged by their physicians to be ineligible for participation in the study
Anyone diagnosed with sleep disorder (International Classification of Sleep Disorders, Second Edition) Participation judged inappropriate by an investigator Unable to attend on any designated study days Unable to comply with the specified sleep/arousal rhythm |
|||
| Target sample size | 8 | |||
| Research contact person | |
| Name of lead principal investigator | Takeshi Yamauchi |
| Organization | Ishinomaki Senshu University |
| Division name | School of Human studies |
| Address | 1 Shinmito Minamisakai Ishinomaki |
| TEL | 0225-22-7711 |
| yamauchi@isenshu-u.ac.jp | |
| Public contact | |
| Name of contact person | Takeshi Yamauchi |
| Organization | Ishinomaki Senshu University |
| Division name | School of human studies |
| Address | 1 Shinmito Minamisakai Ishinomaki |
| TEL | 0225-22-7711 |
| Homepage URL | |
| yamauchi@isenshu-u.ac.jp | |
| Sponsor | |
| Institute | Ishinomaki Senshu University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Grants-in-Aid for Scientific Research |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | A comparison of polysomnography (PSG), heart rate variability analysis, and oxygen desaturation indices (ODI) for low-oxygen trials (15.4% O2) and low-oxygen,
high-carbon dioxide trials (15.4% O2, 1500 ppm CO2) was conducted. No statistical significance was found among Stages N1, N2, N3, and R. The heart rate variability analysis showed no statistical significance among RR interval (RRi), high frequency (HF), and the ratio of low frequency to high frequency (LF/HF). There was no statistical significance among blood oxygen saturation (SpO2), ODI3, and ODI4. The concentration of carbon dioxide (1500 ppm) in the room did not have an adverse effect on the physiological response while sleeping in a low-oxygen environment. |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000022517 |